BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

InnerPulse Appoints W. Eugene Sanders, Jr., M.D. as Vice President of Medical Affairs and Chief Medical Officer


7/10/2007 9:17:33 AM

RESEARCH TRIANGLE PARK, N.C., July 10 /PRNewswire/ -- InnerPulse, Inc., a privately held company with a disruptive technology for the treatment of abnormal heart rhythms, announced the appointment of W. Eugene Sanders, Jr., M.D. to the newly formed position of Vice-President of Medical Affairs and Chief Medical Officer, effective September 2007. Dr. Sanders has more than 15 years of experience in cardiology and related medical specialties including patient care, education and cardiac research at the University of North Carolina at Chapel Hill.

Dr. Sanders, 48, currently serves as Director, Clinical Cardiac Electrophysiology and Pacing; Associate Director, Cardiovascular Diagnostic and Interventional Laboratories; and, Associate Professor of Medicine & Pathology, Division of Cardiology at the University of North Carolina Hospitals.

"We are delighted to have someone with Dr. Sanders' extensive experience join our executive team at this important juncture of the Company's evolution. His background and reputation are critical to our success as we initiate our clinical studies and move closer to gaining regulatory approval of our novel defibrillator technology. His experience as an advisor to the medical technology industry for the past 15 years will provide great value as the Company begins our clinical trials," said InnerPulse President and Chief Executive Officer Daniel A. Pelak.

Dr. Sanders is a graduate of the University of North Carolina, School of Medicine. He also holds an undergraduate degree in chemistry and a master's in business administration from the University of North Carolina. He completed his internal medicine training at the University of North Carolina and fellowships in cardiology and electrophysiology at Baylor College of Medicine and Duke University Medical Center.

About InnerPulse, Inc.

Founded in 2003, InnerPulse is a privately held, early-stage company pioneering an alternative to traditional electrophysiological devices. More information is available at http://www.inner-pulse.com.

Contact: Benny Ward, V.P. & C.F.O Len Hall (media) InnerPulse, Inc Allen & Caron Inc 919 287 4111 949 474 4300 bward@inner-pulse.comlen@allencaron.com

InnerPulse, Inc.

CONTACT: Benny Ward, V.P. & C.F.O of InnerPulse, Inc., +1-919-287-4111,bward@inner-pulse.com; or media, Len Hall of Allen & Caron Inc,+1-949-474-4300, len@allencaron.com, for InnerPulse, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES